Group One Trading, L.P. Protagonist Therapeutics, Inc Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$24.66 - $34.8 $486,418 - $686,430	-19,725 Reduced 69.54%	8,638 $299,000
Q1 2024 May 10, 2024	BUY	$21.79 - $32.15 $618,029 - $911,870	28,363 New	28,363 $820,000
Q4 2022 Feb 09, 2023	SELL	$7.36 - $11.17 $154,236 - $234,078	-20,956 Reduced 94.13%	1,307 $14,000
Q3 2022 Nov 09, 2022	SELL	$7.86 - $11.71 $170,176 - $253,533	-21,651 Reduced 49.3%	22,263 $188,000
Q2 2022 Aug 11, 2022	BUY	$7.06 - $25.52 $232,252 - $839,531	32,897 Added 298.6%	43,914 $347,000
Q1 2022 May 12, 2022	BUY	$23.34 - $36.08 $257,136 - $397,493	11,017 New	11,017 $261,000
Q4 2021 Feb 11, 2022	SELL	$17.63 - $37.1 $31,734 - $66,780	-1,800 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$12.95 - $49.69 $23,310 - $89,442	1,800 New	1,800 $32,000

247

56.4M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.